#GSK #Hepatitis #hepatitisB #virology #bepirovirsen #clinicaltrials #pharmanews #hepBdrug #antisensebaseddrug #chronichepatitisB #CHB #functionalcure #HepBpatients #BWell1trial #BWell2trial #EASL #NEJM #hepatitisBsurfaceantigen #HBsAg #Hepatology #BWelltrial #hepatitisBinfection
zurl.co/pWcfr
zurl.co/pWcfr
GSK hails 'unprecedented' cure rates with hep B drug
The B-Well trials of GSK's bepirovirsen position the antisense drug as a "major step towards a cure for hepatitis B infection," according to experts.
pharmaphorum.com
June 1, 2026 at 9:22 AM